Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2

COVID-19 is a respiratory illness caused by a novel coronavirus called SARS-CoV-2. The viral spike (S) protein engages the human angiotensin-converting enzyme 2 (ACE2) receptor to invade host cells with ~10-15-fold higher affinity compared to SARS-CoV S-protein, making it highly infectious. Here, we...

Full description

Bibliographic Details
Main Authors: Suryamohan, Kushal, Diwanji, Devan, Stawiski, Eric W., Gupta, Ravi, Miersch, Shane, Liu, Jiang, Chen, Chao, Jiang, Ying-Ping, Fellouse, Frederic A., Sathirapongsasuti, J. Fah, Albers, Patrick K., Deepak, Tanneeru, Saberianfar, Reza, Ratan, Aakrosh, Washburn, Gavin, Mis, Monika, Santhosh, Devi, Somasekar, Sneha, Hiranjith, G. H., Vargas, Derek, Mohan, Sangeetha, Phalke, Sameer, Kuriakose, Boney, Antony, Aju, Ustav, Mart, Schuster, Stephan Christoph, Sidhu, Sachdev, Junutula, Jagath R., Jura, Natalia, Seshagiri, Somasekar
Other Authors: Singapore Centre for Environmental Life Sciences and Engineering
Format: Journal Article
Language:English
Published: 2022
Subjects:
Online Access:https://hdl.handle.net/10356/154952
_version_ 1811682292658077696
author Suryamohan, Kushal
Diwanji, Devan
Stawiski, Eric W.
Gupta, Ravi
Miersch, Shane
Liu, Jiang
Chen, Chao
Jiang, Ying-Ping
Fellouse, Frederic A.
Sathirapongsasuti, J. Fah
Albers, Patrick K.
Deepak, Tanneeru
Saberianfar, Reza
Ratan, Aakrosh
Washburn, Gavin
Mis, Monika
Santhosh, Devi
Somasekar, Sneha
Hiranjith, G. H.
Vargas, Derek
Mohan, Sangeetha
Phalke, Sameer
Kuriakose, Boney
Antony, Aju
Ustav, Mart
Schuster, Stephan Christoph
Sidhu, Sachdev
Junutula, Jagath R.
Jura, Natalia
Seshagiri, Somasekar
author2 Singapore Centre for Environmental Life Sciences and Engineering
author_facet Singapore Centre for Environmental Life Sciences and Engineering
Suryamohan, Kushal
Diwanji, Devan
Stawiski, Eric W.
Gupta, Ravi
Miersch, Shane
Liu, Jiang
Chen, Chao
Jiang, Ying-Ping
Fellouse, Frederic A.
Sathirapongsasuti, J. Fah
Albers, Patrick K.
Deepak, Tanneeru
Saberianfar, Reza
Ratan, Aakrosh
Washburn, Gavin
Mis, Monika
Santhosh, Devi
Somasekar, Sneha
Hiranjith, G. H.
Vargas, Derek
Mohan, Sangeetha
Phalke, Sameer
Kuriakose, Boney
Antony, Aju
Ustav, Mart
Schuster, Stephan Christoph
Sidhu, Sachdev
Junutula, Jagath R.
Jura, Natalia
Seshagiri, Somasekar
author_sort Suryamohan, Kushal
collection NTU
description COVID-19 is a respiratory illness caused by a novel coronavirus called SARS-CoV-2. The viral spike (S) protein engages the human angiotensin-converting enzyme 2 (ACE2) receptor to invade host cells with ~10-15-fold higher affinity compared to SARS-CoV S-protein, making it highly infectious. Here, we assessed if ACE2 polymorphisms can alter host susceptibility to SARS-CoV-2 by affecting this interaction. We analyzed over 290,000 samples representing >400 population groups from public genomic datasets and identified multiple ACE2 protein-altering variants. Using reported structural data, we identified natural ACE2 variants that could potentially affect virus-host interaction and thereby alter host susceptibility. These include variants S19P, I21V, E23K, K26R, T27A, N64K, T92I, Q102P and H378R that were predicted to increase susceptibility, while variants K31R, N33I, H34R, E35K, E37K, D38V, Y50F, N51S, M62V, K68E, F72V, Y83H, G326E, G352V, D355N, Q388L and D509Y were predicted to be protective variants that show decreased binding to S-protein. Using biochemical assays, we confirmed that K31R and E37K had decreased affinity, and K26R and T92I variants showed increased affinity for S-protein when compared to wildtype ACE2. Consistent with this, soluble ACE2 K26R and T92I were more effective in blocking entry of S-protein pseudotyped virus suggesting that ACE2 variants can modulate susceptibility to SARS-CoV-2.
first_indexed 2024-10-01T03:54:31Z
format Journal Article
id ntu-10356/154952
institution Nanyang Technological University
language English
last_indexed 2024-10-01T03:54:31Z
publishDate 2022
record_format dspace
spelling ntu-10356/1549522022-05-28T20:11:42Z Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2 Suryamohan, Kushal Diwanji, Devan Stawiski, Eric W. Gupta, Ravi Miersch, Shane Liu, Jiang Chen, Chao Jiang, Ying-Ping Fellouse, Frederic A. Sathirapongsasuti, J. Fah Albers, Patrick K. Deepak, Tanneeru Saberianfar, Reza Ratan, Aakrosh Washburn, Gavin Mis, Monika Santhosh, Devi Somasekar, Sneha Hiranjith, G. H. Vargas, Derek Mohan, Sangeetha Phalke, Sameer Kuriakose, Boney Antony, Aju Ustav, Mart Schuster, Stephan Christoph Sidhu, Sachdev Junutula, Jagath R. Jura, Natalia Seshagiri, Somasekar Singapore Centre for Environmental Life Sciences and Engineering Engineering::Environmental engineering Spike Protein Structural-Analysis COVID-19 is a respiratory illness caused by a novel coronavirus called SARS-CoV-2. The viral spike (S) protein engages the human angiotensin-converting enzyme 2 (ACE2) receptor to invade host cells with ~10-15-fold higher affinity compared to SARS-CoV S-protein, making it highly infectious. Here, we assessed if ACE2 polymorphisms can alter host susceptibility to SARS-CoV-2 by affecting this interaction. We analyzed over 290,000 samples representing >400 population groups from public genomic datasets and identified multiple ACE2 protein-altering variants. Using reported structural data, we identified natural ACE2 variants that could potentially affect virus-host interaction and thereby alter host susceptibility. These include variants S19P, I21V, E23K, K26R, T27A, N64K, T92I, Q102P and H378R that were predicted to increase susceptibility, while variants K31R, N33I, H34R, E35K, E37K, D38V, Y50F, N51S, M62V, K68E, F72V, Y83H, G326E, G352V, D355N, Q388L and D509Y were predicted to be protective variants that show decreased binding to S-protein. Using biochemical assays, we confirmed that K31R and E37K had decreased affinity, and K26R and T92I variants showed increased affinity for S-protein when compared to wildtype ACE2. Consistent with this, soluble ACE2 K26R and T92I were more effective in blocking entry of S-protein pseudotyped virus suggesting that ACE2 variants can modulate susceptibility to SARS-CoV-2. Published version D.D. was supported by an F30 fellowship. Grant number: 1F30CA247147. N.J. was supported by the UCSF Quantitative Biosciences Institute Coronavirus Research Group (QCRG) fellowship. A.R. and S.C.S. were supported by SCELSE. 2022-05-27T02:09:08Z 2022-05-27T02:09:08Z 2021 Journal Article Suryamohan, K., Diwanji, D., Stawiski, E. W., Gupta, R., Miersch, S., Liu, J., Chen, C., Jiang, Y., Fellouse, F. A., Sathirapongsasuti, J. F., Albers, P. K., Deepak, T., Saberianfar, R., Ratan, A., Washburn, G., Mis, M., Santhosh, D., Somasekar, S., Hiranjith, G. H., ...Seshagiri, S. (2021). Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2. Communications Biology, 4(1), 475-. https://dx.doi.org/10.1038/s42003-021-02030-3 2399-3642 https://hdl.handle.net/10356/154952 10.1038/s42003-021-02030-3 33846513 2-s2.0-85104272913 1 4 475 en Communications Biology © 2021 The Author(s). This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/ licenses/by/4.0/. application/pdf
spellingShingle Engineering::Environmental engineering
Spike Protein
Structural-Analysis
Suryamohan, Kushal
Diwanji, Devan
Stawiski, Eric W.
Gupta, Ravi
Miersch, Shane
Liu, Jiang
Chen, Chao
Jiang, Ying-Ping
Fellouse, Frederic A.
Sathirapongsasuti, J. Fah
Albers, Patrick K.
Deepak, Tanneeru
Saberianfar, Reza
Ratan, Aakrosh
Washburn, Gavin
Mis, Monika
Santhosh, Devi
Somasekar, Sneha
Hiranjith, G. H.
Vargas, Derek
Mohan, Sangeetha
Phalke, Sameer
Kuriakose, Boney
Antony, Aju
Ustav, Mart
Schuster, Stephan Christoph
Sidhu, Sachdev
Junutula, Jagath R.
Jura, Natalia
Seshagiri, Somasekar
Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2
title Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2
title_full Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2
title_fullStr Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2
title_full_unstemmed Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2
title_short Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2
title_sort human ace2 receptor polymorphisms and altered susceptibility to sars cov 2
topic Engineering::Environmental engineering
Spike Protein
Structural-Analysis
url https://hdl.handle.net/10356/154952
work_keys_str_mv AT suryamohankushal humanace2receptorpolymorphismsandalteredsusceptibilitytosarscov2
AT diwanjidevan humanace2receptorpolymorphismsandalteredsusceptibilitytosarscov2
AT stawiskiericw humanace2receptorpolymorphismsandalteredsusceptibilitytosarscov2
AT guptaravi humanace2receptorpolymorphismsandalteredsusceptibilitytosarscov2
AT mierschshane humanace2receptorpolymorphismsandalteredsusceptibilitytosarscov2
AT liujiang humanace2receptorpolymorphismsandalteredsusceptibilitytosarscov2
AT chenchao humanace2receptorpolymorphismsandalteredsusceptibilitytosarscov2
AT jiangyingping humanace2receptorpolymorphismsandalteredsusceptibilitytosarscov2
AT fellousefrederica humanace2receptorpolymorphismsandalteredsusceptibilitytosarscov2
AT sathirapongsasutijfah humanace2receptorpolymorphismsandalteredsusceptibilitytosarscov2
AT alberspatrickk humanace2receptorpolymorphismsandalteredsusceptibilitytosarscov2
AT deepaktanneeru humanace2receptorpolymorphismsandalteredsusceptibilitytosarscov2
AT saberianfarreza humanace2receptorpolymorphismsandalteredsusceptibilitytosarscov2
AT ratanaakrosh humanace2receptorpolymorphismsandalteredsusceptibilitytosarscov2
AT washburngavin humanace2receptorpolymorphismsandalteredsusceptibilitytosarscov2
AT mismonika humanace2receptorpolymorphismsandalteredsusceptibilitytosarscov2
AT santhoshdevi humanace2receptorpolymorphismsandalteredsusceptibilitytosarscov2
AT somasekarsneha humanace2receptorpolymorphismsandalteredsusceptibilitytosarscov2
AT hiranjithgh humanace2receptorpolymorphismsandalteredsusceptibilitytosarscov2
AT vargasderek humanace2receptorpolymorphismsandalteredsusceptibilitytosarscov2
AT mohansangeetha humanace2receptorpolymorphismsandalteredsusceptibilitytosarscov2
AT phalkesameer humanace2receptorpolymorphismsandalteredsusceptibilitytosarscov2
AT kuriakoseboney humanace2receptorpolymorphismsandalteredsusceptibilitytosarscov2
AT antonyaju humanace2receptorpolymorphismsandalteredsusceptibilitytosarscov2
AT ustavmart humanace2receptorpolymorphismsandalteredsusceptibilitytosarscov2
AT schusterstephanchristoph humanace2receptorpolymorphismsandalteredsusceptibilitytosarscov2
AT sidhusachdev humanace2receptorpolymorphismsandalteredsusceptibilitytosarscov2
AT junutulajagathr humanace2receptorpolymorphismsandalteredsusceptibilitytosarscov2
AT juranatalia humanace2receptorpolymorphismsandalteredsusceptibilitytosarscov2
AT seshagirisomasekar humanace2receptorpolymorphismsandalteredsusceptibilitytosarscov2